| Genpharmasec Ltd | Industry : (Trading) | |
|---|---|---|
|
BSE Code : 531592 |
NSE Symbol : - |
P/E(TTM) : 24.40 |
|
ISIN Demat : INE861N01036 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.05 |
|
Book Value(₹) : 1.24 |
Market Cap(₹Cr) : 67.55 |
Face Value(₹) : 1.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 36.01 | 31.56 | 12.11 | 13.56 | 8.34 | 5.77 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 36.01 | 31.56 | 12.11 | 13.56 | 8.34 | 5.77 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.43 | 1.00 | 0.82 | 1.06 | 0.93 | 0.86 |
| Total Income | 37.44 | 32.56 | 12.94 | 14.62 | 9.27 | 6.63 |
| Total Expenditure | 36.68 | 31.06 | 11.11 | 14.55 | 7.40 | 5.51 |
| PBIDT | 0.75 | 1.50 | 1.83 | 0.06 | 1.87 | 1.11 |
| Interest | 0.19 | 0.08 | 0.08 | 0.06 | 0.11 | 0.04 |
| PBDT | 0.56 | 1.43 | 1.75 | 0.00 | 1.76 | 1.07 |
| Depreciation | 0.07 | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 |
| Tax | -0.24 | 0.61 | 0.17 | 0.26 | 0.43 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.03 | -0.04 | -0.02 | -0.06 | 0.18 | 0.03 |
| Reported Profit After Tax | 0.76 | 0.82 | 1.56 | -0.23 | 1.11 | 1.00 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.76 | 0.82 | 1.56 | -0.23 | 1.11 | 1.00 |
| EPS (Unit Curr.) | 0.01 | 0.01 | 0.03 | 0.01 | 0.02 | 0.02 |
| EPS (Adj) (Unit Curr.) | 0.01 | 0.01 | 0.03 | 0.01 | 0.02 | 0.02 |
| Calculated EPS (Unit Curr.) | 0.01 | 0.01 | 0.03 | 0.00 | 0.02 | 0.02 |
| Calculated EPS (Adj) (Unit Curr.) | 0.01 | 0.01 | 0.03 | 0.00 | 0.02 | 0.02 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.05 | 0.06 | 0.11 | -0.02 | 0.08 | 0.07 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.05 | 0.06 | 0.11 | -0.02 | 0.08 | 0.07 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 55.37 | 55.37 | 55.37 | 55.37 | 55.37 | 55.37 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 2.08 | 4.75 | 15.11 | 0.44 | 22.42 | 19.24 |
| PBDTM(%) | 1.56 | 4.53 | 14.45 | 0.00 | 21.10 | 18.54 |
| PATM(%) | 2.11 | 2.60 | 12.88 | -1.70 | 13.31 | 17.33 |
